Skip to content
healthcare.dev

INFLIXIMAB

NDC 57894-160, INFLIXIMAB, injection, powder, lyophilized, for solution, from Janssen Biotech, Inc..

Product NDC
57894-160
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103772
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLIXIMAB100 mg/10mL

Pharmacologic classes

Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
57894-160-01578940160011 VIAL, SINGLE-USE in 1 BOX (57894-160-01) / 10 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b05c174f-832c-4321-b34f-2c4ad3742269
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-160

Use it

Look up 57894-160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.